DR. ROY HO HSIN CHEN MD NPI 1720248081

NPI Details

DR. Roy Ho Hsin Chen, MD is a hematology and oncology internal medicine in Riverhead, NY with 18 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Roy Ho Hsin Chen, MD NPI is 1720248081. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: STATE UNIVERSITY OF NY UPSTATE MEDICAL UNIVERSITY
Graduation Year:2008

The provider's business location address is:

750 OLD COUNTRY ROAD BUILDING 2
RIVERHEAD, NY
ZIP 11901
Phone: (631) 751-3000
Fax: (631) 675-2001

The NPI 1720248081 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram (HCPCS:J1442)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Phosphate level (HCPCS:84100)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Magnesium level (HCPCS:83735)
• Uric acid level, blood (HCPCS:84550)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Folic acid level, serum (HCPCS:82746)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Vitamin d-3 level (HCPCS:82306)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Red blood count, manual test (HCPCS:85044)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Blood test, clotting time (HCPCS:85610)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection of drug or substance into vein (HCPCS:96374)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Testosterone (hormone) level, total (HCPCS:84403)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Hemoglobin a1c level (HCPCS:83036)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Urinalysis, manual test (HCPCS:81002)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Drawing of blood for a medical problem (HCPCS:99195)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Acute hepatitis panel (HCPCS:80074)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
• Red blood cell concentration measurement (HCPCS:85014)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Rheumatoid factor level (HCPCS:86431)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Ige (immune system protein) level (HCPCS:82785)
• Injection, ertapenem sodium, 500 mg (HCPCS:J1335)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Bilirubin level, total (HCPCS:82247)
• Phosphatase (enzyme) measurement, acid, total (HCPCS:84060)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Blood smear for iron (HCPCS:85536)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Blood creatinine level (HCPCS:82565)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Liver function blood test panel (HCPCS:80076)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Albumin (protein) level (HCPCS:82040)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Cholesterol level (HCPCS:82465)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Stool analysis for blood to screen for colon tumors (HCPCS:82270)
• Blood glucose (sugar) level (HCPCS:82947)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Thyroid hormone evaluation (HCPCS:84479)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Triglycerides level (HCPCS:84478)
• Measurement of total estradiol (hormone) (HCPCS:82670)
• Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies (HCPCS:87389)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)

The enumeration date for this NPI number is 6/11/2008 and was last updated on 2/3/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: